+1 862-686-2696
Featured Products
Primary Cells
Immortalized Cell Lines
Stem Cells
Tumor Cell Lines
Transfected Stable Cell Lines
Exosomes
MicroRNA Agomir/Antagomir
Nucleic Acid Kits
Explore Products
Cell
Cell
MicroRNA
MicroRNA
Test and Analysis
Test and Analysis
Tumor Cell Lines

KARPAS-422

  • 310
Tumor: lymphoma, follicular, B cell. IgH/bcl2 fusion gene; CD3- CD10+ CD13(+) CD19+ CD20+ CD34+ CD37+ EBV+.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Home | Tumor Cell Lines | Human Tumor Cell Lines | KARPAS-422
Product Code

KARPAS-422; Karpas 422; KARPAS 422; Karpas422; KARPAS422; K422
Species

Human
Cat.No

ABC-TC475S
Product Category Tumor Cell Lines
Size/Quantity

1 vial
Cell Type

Lymphoblast
Shipping Info

Dry Ice
Growth Conditions

37 ℃, 5% CO2
Storage

Liquid Nitrogen
Product Type

Human Lymphoma Cell Lines

Description

KARPAS-422 is a human B-cell non-Hodgkin’s lymphoma (NHL) cell line established from the pleural effusion of a chemotherapy-resistant lymphoma patient, typically an adult. It shows features of mature B-cell neoplasms and displays lymphoblast morphology with irregular cell shape. The cells grow in suspension in RPMI1640 medium supplemented with 10% fetal bovine serum, incubated at 37 °C with 5% CO₂. KARPAS-422 expresses high levels of CD19, CD37, surface immunoglobulins (predominantly IgM and IgG), and CDw52 (CAMPATH-1), shows weak expression of CD10, and lacks CD5 expression. Its unique antigen profile and resistance to chemotherapy make it a valuable model for studying the biology and treatment response of B-cell lymphomas.
AcceGen Frozen Cells & Cell Lines 1 vial
View Product Image

Citation

When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • KARPAS-422KARPAS-422 can be used to explore the mechanism of Cyclin D1-dependent cell cycle dysregulation and the role of abnormal BCR (B cell receptor) signaling pathway in lymphoma progression. In addition, this cell line is also widely used to evaluate the efficacy of BTK inhibitors (such as ibrutinib), BCL-2 inhibitors (such as venetoclax) and proteasome inhibitors, helping to develop new targeted therapies.

  • Online Inquiry
  • Product Reviews

Inquiring KARPAS-422

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

Let's Advance Life Science Research Together

Contact Us
AcceGen Scroll Top Button